These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32994572)

  • 1. COVID vaccine confidence requires radical transparency.
    Nature; 2020 Oct; 586(7827):8. PubMed ID: 32994572
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-vaccine results are on the way - and scientists' concerns are growing.
    Mallapaty S; Ledford H
    Nature; 2020 Oct; 586(7827):16-17. PubMed ID: 32978611
    [No Abstract]   [Full Text] [Related]  

  • 3. Scientists relieved as coronavirus vaccine trial restarts - but question lack of transparency.
    Cyranoski D; Mallapaty S
    Nature; 2020 Sep; 585(7825):331-332. PubMed ID: 32929259
    [No Abstract]   [Full Text] [Related]  

  • 4. Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts.
    Mahase E
    BMJ; 2020 Oct; 371():m4042. PubMed ID: 33093065
    [No Abstract]   [Full Text] [Related]  

  • 5. Covid-19 vaccine trial protocols released.
    Doshi P
    BMJ; 2020 Oct; 371():m4058. PubMed ID: 33087395
    [No Abstract]   [Full Text] [Related]  

  • 6. What China's speedy COVID vaccine deployment means for the pandemic.
    Cyranoski D
    Nature; 2020 Oct; 586(7829):343-344. PubMed ID: 33033397
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use.
    Edwards KM; Orenstein WA
    J Pediatr; 2020 Sep; 224():124-128. PubMed ID: 32565096
    [No Abstract]   [Full Text] [Related]  

  • 8. Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.
    Avorn J; Kesselheim AS
    N Engl J Med; 2020 Oct; 383(18):1706-1708. PubMed ID: 32931162
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
    Schwartz JL
    N Engl J Med; 2020 Oct; 383(18):1703-1705. PubMed ID: 32966716
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
    Trogen B; Oshinsky D; Caplan A
    JAMA; 2020 Jun; 323(24):2460-2461. PubMed ID: 32453392
    [No Abstract]   [Full Text] [Related]  

  • 11. Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
    Krause PR; Fleming TR; Ellenberg SS; Henao-Restrepo AM;
    Lancet; 2020 Nov; 396(10263):1611-1613. PubMed ID: 33125926
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 disrupts vaccine delivery.
    Nelson R
    Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
    [No Abstract]   [Full Text] [Related]  

  • 13. All eyes on a hurdle race for a SARS-CoV-2 vaccine.
    Gaebler C; Nussenzweig MC
    Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943
    [No Abstract]   [Full Text] [Related]  

  • 14. The underdog coronavirus vaccines that the world will need if front runners stumble.
    Callaway E
    Nature; 2020 Sep; 585(7825):332-333. PubMed ID: 32908297
    [No Abstract]   [Full Text] [Related]  

  • 15. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 16. Opinion: It's ethical to test promising coronavirus vaccines against less-promising ones.
    Eyal N; Lipsitch M
    Proc Natl Acad Sci U S A; 2020 Aug; 117(32):18898-18901. PubMed ID: 32699147
    [No Abstract]   [Full Text] [Related]  

  • 17. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
    Boudjelal M; Nehdi A; Islam I
    Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 Vaccines: Status Report.
    Amanat F; Krammer F
    Immunity; 2020 Apr; 52(4):583-589. PubMed ID: 32259480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plan now to speed vaccine supply for future pandemics.
    Bingham K
    Nature; 2020 Oct; 586(7828):171. PubMed ID: 33024331
    [No Abstract]   [Full Text] [Related]  

  • 20. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.